Filing Details

Accession Number:
0001104659-22-065250
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-26 16:05:35
Reporting Period:
2022-05-25
Accepted Time:
2022-05-26 16:05:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1811764 Point Biopharma Global Inc. PNT Pharmaceutical Preparations (2834) 850800493
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1868209 E. Neil Fleshner 4850 West 78Th Street
Indianapolis IN 46268
Chief Medical Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-05-25 564,204 $7.51 3,023,045 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 233,171 Indirect 1510789 Ontario Inc.
Common Stock 358 Indirect Trust Controlled by Wife
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.75, inclusive. The reporting person undertakes to provide to POINT Biopharma Global Inc., any security holder of POINT Biopharma Global Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. A corporation controlled by Reporting Person.
  3. A trust, whose trustee is the Reporting Person's spouse.